Current treatments of rheumatoid arthritis: from the ‘NinJa’ registry

References

• Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 373(9664), 659–672 (2009).
   PubMed Web of Science ®Google Scholar
• Scott DL. Biologics-based therapy for the treatment of rheumatoid arthritis. Clin. Pharmacol. Ther. 91(1), 30–43 (2012).
   PubMed Web of Science ®Google Scholar
• Yazici Y. Long-term safety of methotrexate in the treatment of rheumatoid arthritis. Clin. Exp. Rheumatol. 28(5 Suppl. 61), S65–S67 (2010).
   PubMed Web of Science ®Google Scholar
• ACR Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 46, 328–346 (2002).
   PubMed Web of Science ®Google Scholar
• Saag KG, Teng GG, Patkar NM et al.; American College of Rheumatology. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 59(6), 762–784 (2008).
   PubMed Web of Science ®Google Scholar
• Emery P, Breedveld FC, Hall S et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372(9636), 375–382 (2008).
   PubMed Web of Science ®Google Scholar
• Schoels M, Knevel R, Aletaha D et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann. Rheum. Dis. 69(4), 638–643 (2010).
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod. Rheumatol. 16(2), 75–76 (2006).
   PubMedGoogle Scholar
• Matsui T, Kuga Y, Kaneko A et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann. Rheum. Dis. 66(9), 1221–1226 (2007).
   PubMed Web of Science ®Google Scholar
• Nishino J, Tanaka S, Matsui T et al. Prevalence of joint replacement surgery in rheumatoid arthritis patients: cross-sectional analysis in a large observational cohort in Japan. Mod. Rheumatol. 19(3), 260–264 (2009).
   PubMed Web of Science ®Google Scholar
• Yasui T, Nishino J, Kadono Y et al. Impact of biologics on the prevalence of orthopedic surgery in the National Database of Rheumatic Diseases in Japan. Mod. Rheumatol. 20(3), 233–237 (2010).
   PubMed Web of Science ®Google Scholar
• Matsui T, Kuga Y, Nishino J, Kaneko A, Eto Y, Tohma S. Comparison of composite disease activity indices for rheumatoid arthritis. Mod. Rheumatol. 21(2), 134–143 (2011).
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31(3), 315–324 (1988).
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569–2581 (2010).
   PubMed Web of Science ®Google Scholar
• Van der Heide DM, van ‘t Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J. Rheumatol. 20, 579–581 (1993)
   PubMed Web of Science ®Google Scholar
• Smolen JS, Breedveld FC, Schiff MH et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42(2), 244–257 (2003).
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The simplified disease activity index (SDAI) and clinical disease activity index (CDAI) to monitor patients in standard clinical care. Best Pract. Res. Clin. Rheumatol. 21(4), 663–675 (2007).
   PubMed Web of Science ®Google Scholar
• Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N. Engl. J. Med. 355(7), 704–712 (2006).
   PubMed Web of Science ®Google Scholar
• Visser K, van der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann. Rheum. Dis. 68(7), 1094–1099 (2009).
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Inoue E, Tanaka E et al. Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA). Mod. Rheumatol. 17(2), 98–105 (2007).
   PubMedGoogle Scholar
• Yokota N, Kuga Y, Kanazawa T, Morishita M, Tanida K, Itou K. Ten years results of bucillamine in the treatment of rheumatoid arthritis. Mod. Rheumatol. 17(1), 33–36 (2007).
   PubMedGoogle Scholar
• Abe T, Takeuchi T, Miyasaka N et al. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis. J. Rheumatol. 33(1), 37–44 (2006).
   PubMed Web of Science ®Google Scholar
• Koike T, Harigai M, Inokuma S et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J. Rheumatol. 36(5), 898–906 (2009).
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Hashimoto J, Miyasaka N et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann. Rheum. Dis. 66(9), 1162–1167 (2007).
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Miyasaka N, Inoue K, Abe T, Koike T; RISING study. Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study. Mod. Rheumatol. 19(5), 478–487 (2009).
   PubMed Web of Science ®Google Scholar
• Bathon JM, Martin RW, Fleischmann RM et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N. Engl. J. Med. 343(22), 1586–1593 (2000).
   PubMed Web of Science ®Google Scholar
• Fevang BT, Lie SA, Havelin LI, Engesaeter LB, Furnes O. Reduction in orthopedic surgery among patients with chronic inflammatory joint disease in Norway, 1994–2004. Arthritis Rheum. 57(3), 529–532 (2007).
   PubMed Web of Science ®Google Scholar
• Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann. Rheum. Dis. 66(3), 341–344 (2007).
   PubMed Web of Science ®Google Scholar
• Louie GH, Ward MM. Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983–2007. Ann. Rheum. Dis. 69, 868–871 (2010).
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen J. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin. Exp. Rheumatol. 23(5 Suppl. 39), S100–S108 (2005).
   Google Scholar
• Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum. 52(9), 2625–2636 (2005).
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Bijlsma JW et al.; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69(4), 631–637 (2010).
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Miyasaka N, Tatsuki Y et al. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Ann. Rheum. Dis. 70(7), 1208–1215 (2011).
   PubMed Web of Science ®Google Scholar
• Dirven L, Visser K, Klarenbeek NB et al. Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression. Scand. J. Rheumatol. 41(1), 15–19 (2012).
   PubMed Web of Science ®Google Scholar
• Korpela M, Laasonen L, Hannonen P et al.; FIN-RACo Trial Group. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum. 50(7), 2072–2081 (2004).
   PubMed Web of Science ®Google Scholar
• Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum. 55(6), 864–872 (2006).
   PubMed Web of Science ®Google Scholar
• Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 52(11), 3381–3390 (2005).
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Pesu M, Borie DC, Changelian PS. A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat. Rev. Drug Discov. 3(7), 555–564 (2004).
   PubMed Web of Science ®Google Scholar
• Kremer JM, Bloom BJ, Breedveld FC et al. The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled Phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis Rheum. 60(7), 1895–1905 (2009).
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Kavanaugh A, Burgos-Vargas R et al. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheum. 58(11), 3309–3318 (2008).
   PubMed Web of Science ®Google Scholar
• Ogasawara M, Tamura N, Onuma S et al. Observational cross-sectional study revealing less aggressive treatment in Japanese elderly than nonelderly patients with rheumatoid arthritis. J. Clin. Rheumatol. 16(8), 370–374 (2010).
   PubMed Web of Science ®Google Scholar